Articles by Nathan A. Beaver - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Nathan A. Beaver

Nathan A. Beaver

Senior Counsel

Nathan A, Beaver is a senior counsel in the FDA Practice of Foley & Lardner, LLP.

Final Word: Omnitrope's Approval: What Does It Mean For Other Generics?
August 1, 2006

Congress is not considering legislation that would expand FDA authority to regulate biologics.

ADVERTISEMENT

ADVERTISEMENT

Click here